SLC5A2 and polycystic ovary syndrome: Thus, while mitochondrial dysfunction is present in both SAT and VAT of PCOS rats, SGLT2 inhibition does not appear to decrease adiposity by improving mitochondrial function or oxidative stress in WAT in PCOS rats.